Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 134

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 134
---
 to the purchaser. |

| (b) | The undersigned registrant hereby undertakes that, for purposes                                                                             
 of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a)              
 or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to            
 Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration 
 statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial    
 bona fide offering thereof.                                                                                                                 |

| (c) | Insofar as indemnification for liabilities arising under the                                                                                   
 Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, 
 or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against    
 public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification       
 against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling          
 person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling     
 person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been       
 settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against     
 public policy as expressed in the Securities Act of 1933, as amended, and will be governed by the final adjudication of such issue.            |

<div align='center'>II-5

SIGNATURES</div>

Pursuant to the requirements
of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form F-3 and has duly caused this registration statement on Form F-3 to be signed on its behalf by the undersigned, thereunto
duly authorized, in Zurich, Switzerland on February 10, 2025.

| NLS Pharmaceutics Ltd. |                               |
| By:                    | /s/ Alexander Zwyer           |
|                        | Alexander Zwyer               |
|                        |